Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06327152 · ClinicalTrials.gov registry record · Phase 2

Caffeine Use in the Management of Preterm Infants

A Phase 2 study of Apnea of Prematurity, sponsored by University of California, Irvine.

Active
Registry status
Phase 2
Development phase
80
Enrollment target
1
Study location

NCT06327152 is a Phase 2 study of Apnea of Prematurity that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 80 participants, below the 395-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06327152, a Phase 2 study of Apnea of Prematurity, is active but no longer recruiting, sponsored by University of California, Irvine.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess whether extending the duration of caffeine therapy will help preterm infants achieve full oral feeding faster.

Conditions Studied

Apnea of Prematurity

Interventions

  • DRUG Caffeine
  • OTHER Sterile Water Placebo

Study Locations (1)

California

  • UC Irvine Medical Center - Orange

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-02-22
Est. Completion 2026-12-31
Phase Phase 2

Sponsor

University of California, Irvine

368 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06327152

The ClinicalTrials.gov registry entry for NCT06327152 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 395-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (80% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Apnea of Prematurity appearing as the primary indexed condition, and to 2 interventions - of which Caffeine is the first listed.

NCT06327152 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06327152 about?

NCT06327152 is a clinical study titled "Caffeine Use in the Management of Preterm Infants". This study aims to assess whether extending the duration of caffeine therapy will help preterm infants achieve full oral feeding faster.

What is the current status of trial NCT06327152?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2024-02-22. Estimated completion is 2026-12-31.

What conditions does trial NCT06327152 study?

This clinical trial studies the following conditions: Apnea of Prematurity.

What interventions are being tested in trial NCT06327152?

The interventions under investigation include: Caffeine (DRUG), Sterile Water Placebo (OTHER).

Who is sponsoring clinical trial NCT06327152?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06327152 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Apnea of Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Apnea of Prematurity

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.